Financials
Value Q1, 25Q2, 25Q3, 25 TTM Selling/general/admin expenses 2.42 M2.25 M2.21 M 8.87 M Research & development ——— — Operating income 752 K742 K957 K 3.68 M Non-Operating Income, Total 99 K100 K98 K — Interest expense, net of interest capitalized ——— — Non-Operating Income, excl. Interest Expenses 99 K100 K98 K — Unusual income/expense 8 0009 0000 — Pretax income 851 K842 K1.05 M 3.97 M Equity in earnings ——— — Taxes 206 K205 K255 K 1.04 M Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations 645 K637 K800 K 2.93 M Discontinued operations ——— — Net income 645 K637 K800 K 2.93 M Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders 645 K637 K800 K 2.93 M Basic earnings per share (Basic EPS) 0.050.040.06 0.21 Diluted earnings per share (Diluted EPS) 0.050.040.06 0.21 Average basic shares outstanding 14.21 M14.21 M14.21 M — Diluted shares outstanding 14.28 M14.28 M14.3 M — EBITDA 800 K837 K1.14 M 4.38 M EBIT 833 K821 K1.04 M 4.29 M Cost of revenue 4 0007 0009 000 21 K Other cost of goods sold ——— — Depreciation & amortization (cash flow) -33 K16 K93 K 183 K